Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Kang, Josephine ^a   Chen, Ming Hui ^b   Zhang, Yuanye ^b   Moran, Brian J ^c   Dosoretz, Daniel E ^d   Katin, Michael J ^d   Braccioforte, Michelle H ^c   Salenius, Sharon A ^d   D'Amico, Anthony V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Prostate Cancer Foundation of Chicago   (United States)

^d 21 Century Oncology Inc   (United States)

Author keywords

Gleason score; Prostate cancer; PSA; Type I diabetes; Type II diabetes

Indexed keywords

GLEASON SCORES; PROSTATE CANCERS; PSA; TYPE I DIABETES; TYPE II;

RADIOTHERAPY; REGRESSION ANALYSIS;

DISEASES;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIOPSY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ODDS RATIO; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 84856385887     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.003     Document Type: Article

References (22)

1. L.A.G. Ries, D. Melbert, M. Krapcho, A. Mariotto, B.A. Miller, E.J. Feuer, L. Clegg, M.J. Horner, N. Howlader, M.P. Eisner, M. Reichman, and B.K. Edwards SEER Cancer Statistics Review, 1975-2004 2007 National Cancer Institute Bethesda, MD
2. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
3. T. Mitin, M.H. Chen, and B.J. Moran Diabetes mellitus, race, and the odds of high-grade prostate cancer in men diagnoesd with prostate cancer in the United States J Clin Oncol 29 Suppl 7 2011 abstr p. 180
4. B.B. Barone, H.C. Yeh, and C.F. Snyder Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis JAMA 300 2008 2754 2764
5. E. Giovannucci, D.M. Harlan, and M.C. Archer Diabetes and cancer: A consensus report Diabetes Care 33 2010 1674 1685
6. D.M. Maahs, N.A. West, J.M. Lawrence, and E.J. Mayer-Davis Epidemiology of type 1 diabetes Endocrinol Metab Clin North Am 39 2010 481 497
7. R.J. Koopman, A.G. Mainous 3rd, V.A. Diaz, and M.E. Geesey Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000 Ann Fam Med 3 2005 60 63
8. Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62 S69
9. A. Agresti Categorical data analysis Second edition 2002 Wiley New York, NY
10. M. Hollander, and D.A. Wolfe Nonparametric statistical methods 1999 Wiley New York, NY
11. A.V. D'Amico, M.H. Braccioforte, B.J. Moran, and M.H. Chen Causes of death in men with prevalent diabetes and newly diagnosed high- vs. favorable-risk prostate cancer Int J Radiat Oncol Biol Phys 77 2010 1329 1337
12. P. Vigneri, F. Frasca, and L. Sciacca Diabetes and cancer Endocr Relat Cancer 16 2009 1103 1123
13. S.S. Coughlin, E.E. Calle, and L.R. Teras Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults Am J Epidemiol 159 2004 1160 1167
14. L.C. Richardson, and L.A. Pollack Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer Nat Clin Pract Oncol 2 2005 48 53
15. R.C. van Kruijsdijk, E. van der Wall, and F.L. Visseren Obesity and cancer: The role of dysfunctional adipose tissue Cancer Epidemiol Biomarkers Prev 18 2009 2569 2578
16. Y.X. Yang, S. Hennessy, and J.D. Lewis Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 2004 1044 1050
17. D. Weinstein, M. Simon, and E. Yehezkel Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells Diabetes Metab Res Rev 25 2009 41 49
18. M. Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome Nat Rev Endocrinol 5 2009 673 681
19. G. Schatzl, S. Madersbacher, and T. Thurridl High-grade prostate cancer is associated with low serum testosterone levels Prostate 47 2001 52 58
20. M.A. Hoffman, W.C. DeWolf, and A. Morgentaler Is low serum free testosterone a marker for high grade prostate cancer? J Urol 163 2000 824 827
21. D.J. Sher, C. Mantzoros, and S. Jacobus Absence of relationship between steroid hormone levels and prostate cancer tumor grade Urology 73 2009 356 361 discussion 361-352
22. A. Decensi, M. Puntoni, and P. Goodwin Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis Cancer Prev Res 3 2010 1451 1461